A clinical trial will test a medication in people without symptoms to verify if it is possible to prevent Alzheimer's disease. The objective is to determine whether the medication can prevent the development of the disease before the first signs even appear.
Healthy middle-aged people considered at high risk for developing Alzheimer's are among the eligible participants for the study. These people will be followed throughout the trial to evaluate the effects of the medication.
The approach represents a shift in the research strategy for the disease, focusing on prevention rather than only on treating existing symptoms. The researchers intend to identify possible interventions before the brain damage becomes significant.
